ClinConnect ClinConnect Logo
Search / Trial NCT07051759

Back Rolls Assessment

Launched by HAGER MONTASER SAYED BEDEER · Jul 3, 2025

Trial Information

Current as of July 12, 2025

Not yet recruiting

Keywords

Back Rolls Management Back Rolls Assessment

ClinConnect Summary

This clinical trial is studying different ways to assess and manage "back rolls," which are folds or rolls of fat that can appear on the back, especially in women. The study aims to better understand how these fat rolls vary in size and location, and how to classify them to help doctors choose the best treatment. Treatments can include liposuction (a procedure that removes fat), surgical removal of the skin fold, or non-surgical options like injections combined with weight loss. The goal is to find the most effective approach depending on each person’s specific back rolls.

Women between the ages of 18 and 50 who have any amount of back rolls may be eligible to join the study. However, women with certain health problems, abnormal lab test results, or who have had previous back surgeries or liposuction are not eligible. Participants can expect to have their back rolls assessed carefully to determine the best treatment plan. This study is not yet open for recruiting, but it hopes to provide clearer guidance for managing back rolls in the future.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Female patients aged 18 to 50 years old.
  • Any grad of back rolls
  • Exclusion Criteria:
  • patients outside the selected age range
  • Abnormal laboratory tests (in particular, glucose \>105 g/dL, hemoglobin \<12 g/dL, platelets \<150,000)
  • significant systemic diseases.
  • previous liposuction or other back surgeries.

About Hager Montaser Sayed Bedeer

Hager Montaser Sayed Bedeer is a clinical trial sponsor dedicated to advancing medical research through the design and support of innovative clinical studies. Committed to improving patient outcomes, the sponsor collaborates with healthcare professionals and research institutions to ensure rigorous study conduct, ethical standards, and the generation of high-quality data that contribute to evidence-based medicine.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported